Investment analysts at StockNews.com initiated coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) in a report issued on Wednesday. The brokerage set a “sell” rating on the basic materials company’s stock.
Separately, HC Wainwright reissued a “buy” rating and issued a $6.00 price target on shares of Arcadia Biosciences in a research report on Wednesday, August 21st.
Get Our Latest Research Report on Arcadia Biosciences
Arcadia Biosciences Price Performance
Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last issued its quarterly earnings data on Tuesday, August 13th. The basic materials company reported $0.78 EPS for the quarter, missing analysts’ consensus estimates of $1.27 by ($0.49). Arcadia Biosciences had a negative return on equity of 57.51% and a negative net margin of 127.29%. The company had revenue of $1.31 million for the quarter, compared to the consensus estimate of $0.95 million. During the same period in the prior year, the firm posted ($2.64) earnings per share. On average, equities research analysts expect that Arcadia Biosciences will post -1.7 earnings per share for the current fiscal year.
About Arcadia Biosciences
Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
Read More
- Five stocks we like better than Arcadia Biosciences
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Is McDonald’s Stock a Smart Buy After Sell-Off and Earnings?
- Best Stocks Under $5.00
- QuantumScape: Solid State EV Batteries Nearing Commercialization
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- MicroStrategy: Is This Bitcoin-Powered Stock a Buy or a Gamble?
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.